about
Nucleases in homologous recombination as targets for cancer therapyEpigenetic reduction of DNA repair in progression to gastrointestinal cancerPredictive biomarkers for triple negative breast cancer treated with platinum-based chemotherapy.Targeting Ongoing DNA Damage in Multiple Myeloma: Effects of DNA Damage Response Inhibitors on Plasma Cell Survival.Latexin sensitizes leukemogenic cells to gamma-irradiation-induced cell-cycle arrest and cell death through Rps3 pathway.DNA damage response markers are differentially expressed in BRCA-mutated breast cancersBRUCE regulates DNA double-strand break response by promoting USP8 deubiquitination of BRIT1.Approaches to identifying synthetic lethal interactions in cancer.Small Molecule Inhibitors of 8-Oxoguanine DNA Glycosylase-1 (OGG1).Targeting WISP1 to sensitize esophageal squamous cell carcinoma to irradiation.A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma Cells.Selective Nuclear Export Inhibitor KPT-330 Enhances the Antitumor Activity of Gemcitabine in Human Pancreatic CancerMaternal diabetes triggers DNA damage and DNA damage response in neurulation stage embryos through oxidative stress.DNA Damage Response Proteins and Oxygen Modulate Prostaglandin E2 Growth Factor Release in Response to Low and High LET Ionizing Radiation.Mechanism of action studies of lomaiviticin A and the monomeric lomaiviticin aglycon. Selective and potent activity toward DNA double-strand break repair-deficient cell lines.Harmine suppresses homologous recombination repair and inhibits proliferation of hepatoma cells.Suppression of STN1 enhances the cytotoxicity of chemotherapeutic agents in cancer cells by elevating DNA damage.Cell-free Xenopus egg extracts for studying DNA damage response pathways.FANCD2 functions as a critical factor downstream of MiTF to maintain the proliferation and survival of melanoma cellsWRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells.ARRB1 enhances the chemosensitivity of lung cancer through the mediation of DNA damage responseRadiation-induced signaling pathways that promote cancer cell survival (review).Radiogenomics helps to achieve personalized therapy by evaluating patient responses to radiation treatment.Embracing synthetic lethality of novel anticancer therapies.A comprehensive look of poly(ADP-ribose) polymerase inhibition strategies and future directions for cancer therapy.Enhanced gefitinib-induced repression of the epidermal growth factor receptor pathway by ataxia telangiectasia-mutated kinase inhibition in non-small-cell lung cancer cells.Inhibition of exportin-1 function results in rapid cell cycle-associated DNA damage in cancer cells.RNA sequencing-based cell proliferation analysis across 19 cancers identifies a subset of proliferation-informative cancers with a common survival signature.Melatonin: A pleiotropic molecule that modulates DNA damage response and repair pathways.Mitotic DNA Damage Response: At the Crossroads of Structural and Numerical Cancer Chromosome Instabilities.Differential expression profile analysis of DNA damage repair genes in CD133+/CD133- colorectal cancer cells.The plant-specific CDKB1-CYCB1 complex mediates homologous recombination repair in ArabidopsisAlbendazole as a promising molecule for tumor control.IGF-1R inhibition sensitizes breast cancer cells to ATM-related kinase (ATR) inhibitor and cisplatin.The Immortal Senescence.New insights into tumor dormancy: Targeting DNA repair pathways.Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers.Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases.Enhanced Radiotherapy using Bismuth Sulfide Nanoagents Combined with Photo-thermal Treatment.
P2860
Q26822478-FFA5ACDB-025B-4E8C-9349-93C55547BD74Q28262162-A2E362B8-5DF4-4B76-BCF3-7D83BEB29ADAQ33441772-5CD8E80B-938C-4C54-B009-A9D5ACF4A3DBQ33705389-C215C240-4C9A-4831-B8D4-ECF158C91DC1Q34541675-1A7C764C-502B-4AC2-8183-5C60AA49D86EQ35131267-56063D7A-DDF5-4633-8908-87C3A2F6EFFEQ35212757-06852404-1E24-427D-AFC7-8AF9E5D89912Q35647469-9BCD2698-1837-41C4-B59B-54A0DAFA002CQ35720072-9222A13E-E18A-4D98-8E27-2E8CB704032BQ35742509-200BD1AA-A64D-4DE3-97F3-1810F18AECCAQ35870483-F11B1DED-3420-46D6-AEE6-BCBB2D22B52EQ35881648-53A604CA-901B-481D-87CF-379A996B6A88Q36078792-DEEDA02B-423A-4CEF-BE8E-14638ABAEA39Q36200213-F837E76F-72CC-451A-9F2F-CD7888729D72Q36349712-3B265AD6-D5D9-40CD-AB6A-0D8AA42537C3Q36837700-477E782E-35DC-4484-8C04-D45A88A317B5Q36839039-77487319-A08E-42CA-8323-3E30364E041BQ37108298-9FEFB6FE-D4C8-451A-BDCC-4436B2B501C5Q37351727-A2A5F27D-A17B-4823-A326-E995EADAB475Q37402621-BD0BDAD5-A395-488D-93F7-FFEFB8EAEBD3Q37405945-E3079136-7790-45F2-8AA4-1CC587593087Q37707633-5B74A18F-2029-48CC-B0FB-AAF615D26568Q38244964-0E81156D-877B-4277-80A4-CABD3CA64848Q38325595-76C1C4C3-1BC1-42B9-BFF1-87F5E9A9F85EQ38554530-22A6C370-C106-4280-B266-9C8F86A64F25Q38780396-8E696D7D-B038-4A8B-8681-BD9F5F016DDAQ38798148-7D919D19-1538-4A93-B880-339D5C4A0CF2Q38806892-99ED2979-F667-4D61-B4C8-EF281946FB06Q38814218-5B5F7517-73BE-4094-A680-EAB02A085BEDQ39260655-9594EC07-CB83-4F65-B34C-399084A23011Q39441343-10870E67-3756-4F1A-89C2-44FAAF15C56FQ41144456-3EC05283-8820-4CB8-911B-002A499A4682Q41292927-2CD0416C-7587-4155-A4FE-A42A37F9CF7CQ41348862-71D95F5F-2805-4F41-881B-49C27B797ABDQ42322249-BB3BCC40-9F78-4C5B-972C-1891CFD749B6Q42380380-B03C1FE8-E326-49DC-BB6E-C334943E4F55Q43227475-D0E5FBD5-C796-44BA-820C-5C108C8EB5EDQ45790068-1942B312-98F0-4A79-B7F7-A1E51D102366Q46063736-1F23CD35-5135-4090-A30A-12F3D49CE704Q47329255-32CA8218-9269-44EF-AB58-2F20AC899AD2
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeting DNA damage response in cancer therapy
@ast
Targeting DNA damage response in cancer therapy
@en
Targeting DNA damage response in cancer therapy
@nl
type
label
Targeting DNA damage response in cancer therapy
@ast
Targeting DNA damage response in cancer therapy
@en
Targeting DNA damage response in cancer therapy
@nl
prefLabel
Targeting DNA damage response in cancer therapy
@ast
Targeting DNA damage response in cancer therapy
@en
Targeting DNA damage response in cancer therapy
@nl
P2860
P921
P3181
P356
P1433
P1476
Targeting DNA damage response in cancer therapy
@en
P2093
Kiyoshi Miyagawa
Noriko Hosoya
P2860
P304
P3181
P356
10.1111/CAS.12366
P407
P5008
P577
2014-04-01T00:00:00Z